Literature DB >> 19033806

F-18 FDG PET/CT evaluation of sacrococcygeal chordoma.

Soon-Ah Park1, Hun Soo Kim.   

Abstract

Chordoma is a rare malignant bone tumor derived from notochordal rests, and the most common site is the sacrococcygeal region. A 52-year-old woman presented with a sacrococcygeal chordoma detected on F-18 fluorodeoxyglucose (FDG) positron emission tomography (PET)/computed tomography (CT). The F-18 FDG PET/CT showed a large destructive mass that arose anteriorly in the sacrococcygeal region and heterogeneously increased FDG uptake within the mass was observed. After surgery, histology confirmed the presence of a sacrococcygeal chordoma. The physician should take chordoma into consideration if there is a large osteolytic mass with hypermetabolism in the sacral region on FDG PET/CT.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 19033806     DOI： 10.1097/RLU.0b013e31818c4e88

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


  15 in total

Review 1.  Imaging features of primary and secondary malignant tumours of the sacrum.

Authors:  E Thornton; K M Krajewski; K N O'Regan; A A Giardino; J P Jagannathan; N Ramaiya
Journal:  Br J Radiol       Date:  2011-12-13       Impact factor: 3.039

Review 2.  Current therapeutic options and novel molecular markers in skull base chordomas.

Authors:  Filippo Gagliardi; Nicola Boari; Paola Riva; Pietro Mortini
Journal:  Neurosurg Rev       Date:  2011-10-18       Impact factor: 3.042

Review 3.  An overview of the role of cancer stem cells in spine tumors with a special focus on chordoma.

Authors:  Mojdeh Safari; Alireza Khoshnevisan
Journal:  World J Stem Cells       Date:  2014-01-26       Impact factor: 5.326

4.  Osseous metastases of chordoma: imaging and clinical findings.

Authors:  Connie Chang; Ivan Chebib; Martin Torriani; Miriam Bredella
Journal:  Skeletal Radiol       Date:  2017-01-07       Impact factor: 2.199

5.  Chordoma: 18F-FDG PET/CT and MRI imaging features.

Authors:  Joshua T Olson; Doris E Wenger; Peter S Rose; Ivy A Petersen; Stephen M Broski
Journal:  Skeletal Radiol       Date:  2021-02-01       Impact factor: 2.199

6.  Clival chordoma with drop metastases.

Authors:  Faimee Erwan Muhamat Nor; Vijayadwaja Desai; Lee Lian Chew
Journal:  J Radiol Case Rep       Date:  2018-03-31

7.  Metastatic Chordoma: Report of the Two Cases and Review of the Literature.

Authors:  Saurabh Rohatgi; Nikhil H Ramaiya; Jyothi P Jagannathan; Stephanie A Howard; Atul B Shinagare; Katherine M Krajewski
Journal:  Eurasian J Med       Date:  2015-06

Review 8.  The biological basis for modern treatment of chordoma.

Authors:  Roberto Jose Diaz; Michael D Cusimano
Journal:  J Neurooncol       Date:  2011-03-08       Impact factor: 4.130

Review 9.  Parosteal extra-axial chordoma of the second metacarpal bone: a case report with literature review.

Authors:  Shinji Tsukamoto; Daniel Vanel; Alberto Righi; Davide Maria Donati; Costantino Errani
Journal:  Skeletal Radiol       Date:  2017-11-18       Impact factor: 2.199

10.  In vitro characterization of cells derived from chordoma cell line U-CH1 following treatment with X-rays, heavy ions and chemotherapeutic drugs.

Authors:  Takamitsu A Kato; Akihisa Tsuda; Mitsuru Uesaka; Akira Fujimori; Tadashi Kamada; Hirohiko Tsujii; Ryuichi Okayasu
Journal:  Radiat Oncol       Date:  2011-09-14       Impact factor: 3.481
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.